Diabetes Kongress 2019
zur Liste
Sebastian Kloss
Bayer AG Germany
  • Vortrag Comparative safety and effectiveness of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and diabetes Speaker
    Datum: 31.05.2019 , Zeit: 11:50 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details